Trial NCT00354900

View at ClinicalTrials.gov 
Org. Study IDs: D-0540

Last trial update was posted on 2009-08-04

MeSH Interventions

Aprotinin

MeSH Conditions

Breast Neoplasms

Other Conditions

Metastatic Breast Cancer

Stopping Reasons

The FDA changed the labeling for this agent, and we felt we could not offer it to patients on a non-surgical study.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID